+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Antacids Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • PDF Icon

    Report

  • 200 Pages
  • April 2025
  • Region: Global
  • Renub Research
  • ID: 5696919

Global Antacids Market will reach US$ 10.50 Billion in 2027. Industry Trends By Product, Application, End User, Impact of Inflation, Company Analysis, Global Forecast 2023-2027

Tea Market is expected to reach US$ 10.11 billion by 2033 from US$ 7.15 billion in 2024, with a CAGR of 3.93% from 2025 to 2033. The market is expanding primarily due to the increase of retail pharmacies, the growing number of patients suffering from gastroesophageal reflux disease (GERD), and the desire for over-the-counter medications.

The report Antacids Global Market covers by Drug Class (Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents) Formulation Type (Tablets, Liquid, Powder, Others) Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy) Countries and Company Analysis, 2025-2033.

Global Antacids Industry Overview

Antacids are drugs used to counteract too much stomach acid. They provide alleviation for symptoms such as acid reflux, indigestion, and heartburn. By raising the pH of the stomach's contents, antacids reduce acidity and ease the discomfort that comes with high stomach acid levels, which are acidic. Antacids are a practical way for people to self-treat minor symptoms because they are available without a prescription. They are commonly accessible over-the-counter in a variety of forms, such as chewable pills, liquids, and tablets. They provide immediate symptom relief. Antacids have several advantages, such as their quick effectiveness, availability over-the-counter, and variety of formulations to suit personal tastes. For treating the temporary symptoms of excessive stomach acid, antacids are easily obtained and efficient solutions. They currently come in a variety of forms and are effective in terms of flavor and taste.

A 2022 National Institutes of Health (NIH) study found that 783.95 million persons worldwide received a GERD diagnosis in 2019. Between 1990 and 2019, the overall number of years lived with disability (YLD) increased by 77.19%, while the total number of prevalent cases and incident cases climbed by 77.53% and 74.79%, respectively.

Additionally, the need for antacids is being driven by e-commerce, and because of the convenience they provide, online retail channels are expanding quickly. Therefore, the market's overall growth is being positively impacted by the rising popularity of e-commerce and the expanding number of online healthcare providers.

The adverse consequences of antacid use are one of the main obstacles facing the antacid market. Common antacid adverse effects include dose-dependent rebound hyperacidity and the milk-alkali syndrome. Furthermore, adverse side effects such osteomalacia, hypophosphatemia, constipation, and metal poisoning can occur from antacids that include aluminum hydroxide. The market's expansion is expected to be constrained by the growing concerns regarding these negative effects.

Growth Drivers for the Antacids Market

Shifting demography as a result of the growing number of elderly people

Antacids are becoming more and more important to the elderly due to their ability to quickly relieve acidity. As a result, they frequently purchase or ingest antacids to treat these stomach problems. One could argue that antacid sales globally may be higher in countries with higher rates of aging populations. One in six people will be 60 years of age or older by 2030 and 2050, according to 2022 World Health Organization (WHO) research. Additionally, there will be 2.1 billion people over 60 in the world, up from 1.4 billion in 2020.

The rising incidence of acidity and heartburn

Heartburn and indigestion are becoming more common as a result of dietary and lifestyle changes linked to irregular eating habits and increased consumption of spicy or acidic foods. Factors like obesity and other contemporary lifestyle choices are to blame for the increase in acid-related problems, such as gastroesophageal reflux disease (GERD). Digestive issues are made worse by stress, sedentary lifestyles, and unpredictable sleep patterns. Antacids are often used for self-treatment since they are readily available over-the-counter. Thus, given the changes in lifestyle, the rising incidence of indigestion and related disorders will support the expansion of the worldwide antacid market.

Rising Stress and Anxiety Levels

An important factor in the rising need for antacids is the rise in stress and anxiety levels. By raising the production of stomach acid, stress and emotional discomfort can impair digestive health and cause common problems like acid reflux, heartburn, and indigestion. There is a greater dependence on over-the-counter antacid drugs for treatment as more people suffer from these symptoms as a result of contemporary stressors. Antacids are a handy choice for people looking for immediate symptom relief without a prescription because they are readily available at pharmacies and supermarkets. The market for antacids is expanding due to the rise in self-medication brought on by growing awareness of digestive health. The demand for antacid solutions is predicted to climb further as the number of digestive problems linked to stress continues to rise.

Challenges in the Antacids Market

Side Effects and Overuse Concerns

Constipation, diarrhea, and an imbalance in stomach acidity are just a few of the adverse effects that can result from using antacids too frequently or excessively. While overuse of antacids, especially those with calcium or aluminum, might result in constipation, tablets with magnesium can cause diarrhea. Additionally, prolonged use might upset the stomach's natural acid-base balance, which can impact nutrient absorption and digestion. Furthermore, an excessive dependence on antacids may conceal underlying illnesses including ulcers, GERD, or other gastrointestinal diseases. This may postpone an accurate diagnosis and course of treatment, which over time may result in more serious health problems. In order to prevent long-term issues, users are therefore encouraged to use antacids carefully and consult a doctor for recurrent problems.

Competition from Alternative Remedies

The market for conventional antacids is facing competition from the rising popularity of home and natural therapies. To treat heartburn and indigestion symptoms, more customers are increasingly using herbal remedies like peppermint, chamomile, or ginger in addition to dietary adjustments. When compared to pharmaceutical antacids, these substitutes are frequently thought to be safer, more natural, and less likely to cause negative side effects. Furthermore, better dietary practices and stress reduction are two lifestyle changes that are increasingly being used to treat digestive problems. Some consumers are turning away from traditional antacid treatments as awareness of these alternative therapies grows, putting pressure on pharmaceutical businesses to compete. Long-term growth potential in the antacids market may be constrained by this tendency.

United States Antacids Market

The market for antacids in the US is steadily expanding due to a rise in gastrointestinal conditions such heartburn, acid reflux, and indigestion. More consumers are using over-the-counter antacid medicines for immediate and efficient relief as digestive health becomes more well recognized. To accommodate different consumer preferences, the market is further supported by a broad variety of antacid formulations, such as chewable pills, liquids, and effervescent solutions. The increasing need for antacids is also a result of sedentary lifestyles, poor diets, and stress. Long-term market development, however, can be impacted by worries about antacid misuse and other adverse effects. Despite this, antacids are becoming more widely available in pharmacies and supermarkets, which guarantees high market demand and accessibility.

Germany Antacids Market

The rising incidence of gastrointestinal conditions such heartburn, acid reflux, and indigestion, especially among the elderly population, is driving growth in the German antacid industry. Due to increased awareness of digestive health and the ease of accessing products, consumers are increasingly resorting to over-the-counter antacids for quick relief. A robust healthcare system and the growing popularity of self-medication are factors that support the market. The market is also growing as a result of improvements in antacid formulations, such as more practical and efficient administration systems including chewable tablets and effervescent powders. However, issues may arise due to worries about antacid misuse and possible adverse consequences. In spite of this, antacid demand is still high in Germany due to increased consumer health consciousness and easier access to medical supplies.

India Antacids Market

The growing incidence of gastrointestinal conditions like heartburn, acid reflux, and indigestion is driving significant growth in the Indian antacid industry. The nation's antacid product demand is rising as a result of stress, poor diets, and changes in lifestyle. More people are using over-the-counter antacids for immediate relief due to the big population and growing awareness of digestive health. Market expansion is also fueled by the availability of different formulations, including beverages, effervescent pills, and chewable tablets. Antacids are also simpler to find in pharmacies and retail stores as the middle class grows and healthcare infrastructure advances. The Indian antacid industry is anticipated to keep expanding as consumer health consciousness rises, despite obstacles including limited knowledge in rural areas.

United Arab Emirates Antacids Market

In the United Arab Emirates (UAE), the market for antacids is growing as a result of an increase in gastrointestinal conditions such heartburn, acid reflux, and indigestion brought on by stress, poor diets, and sedentary lifestyles. More people are turning to over-the-counter antacids for relief as digestive health knowledge rises. The market's expansion is further supported by the UAE's sophisticated healthcare system and high purchasing power, which offer a large range of antacid formulations, such as chewable pills, liquids, and effervescent products. Demand is also driven by consumers' growing appetite for quick-fixing, convenient solutions. Despite ongoing worries about abuse and possible adverse consequences, the industry is expanding because to rising demand, especially from urban populations, for easily accessible digestive health remedies.

Antacids Market Segments

Drug Class - Market in 4 Viewpoints:

1. Proton Pump Inhibitors
2. H2 Antagonist
3. Acid Neutralizers
4. Pro-Motility Agents

Formulation Type - Market in 4 Viewpoints:

1. Tablets
2. Liquid
3. Powder
4. Others

Distribution Channel - Market in 3 Viewpoints:

1. Retail Pharmacy
2. Hospital Pharmacy
3. Online Pharmacy

Country

North America

1. United States
2. Canada

Europe

1. France
2. Germany
3. Italy
4. Spain
5. United Kingdom
6. Belgium
7. Netherlands
8. Turkey

Asia Pacific

1. China
2. Japan
3. India
4. Australia
5. South Korea
6. Thailand
7. Malaysia
8. Indonesia
9. New Zealand

Latin America

1. Brazil
2. Mexico
3. Argentina

Middle East & Africa

1. South Africa
2. Saudi Arabia
3. United Arab Emirates

Company Insights:

  • Overviews
  • Key Persons
  • Recent Developments
  • Revenue

Company Analysis:

1. Abbott Laboratories
2. AstraZeneca plc
3. Bayer AG
4. Boehringer Ingelheim International GmbH
5. Dr. Reddy’s Laboratories Ltd.

6. GlaxoSmithKline plc
7. Johnson & Johnson
8. Pfizer Inc.

9. Procter & Gamble Company
10. Sanofi S.A.

11. Sun Pharmaceutical Industries Ltd.

12. Takeda Pharmaceutical Company Limited
12. Takeda Pharmaceutical Company Limited

Table of Contents

1. Introduction2. Research Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Antacids Market
6. Market Share
6.1 Drug Class
6.2 Formulation Type
6.3 Distribution Channel
6.4 Country
7. Drug Class
7.1 Proton Pump Inhibitors
7.2 H2 Antagonist
7.3 Acid Neutralizers
7.4 Pro-Motility Agents
8. Formulation Type
8.1 Tablets
8.2 Liquid
8.3 Powder
8.4 Others
9. Distribution Channel
9.1 Retail Pharmacy
9.2 Hospital Pharmacy
9.3 Online Pharmacy
10. By Country - Global Antacids Market
10.1 North America
10.1.1 United States
10.1.2 Canada
10.2 Europe
10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 Australia
10.3.5 South Korea
10.3.6 Thailand
10.3.7 Malaysia
10.3.8 Indonesia
10.3.9 New Zealand
10.4 Latin America
10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina
10.5 Middle East & Africa
10.5.1 South Africa
10.5.2 Saudi Arabia
10.5.3 UAE
11. Porter’s Five Analysis
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes
12. SWOT Analysis
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat
13. Company Analysis
13.1 Abbott Laboratories
13.1.1 Overview
13.1.2 Recent Developments
13.1.3 Revenue
13.2 AstraZeneca plc
13.2.1 Overview
13.2.2 Recent Developments
13.2.3 Revenue
13.3 Bayer AG
13.3.1 Overview
13.3.2 Recent Developments
13.3.3 Revenue
13.4 Boehringer Ingelheim International GmbH
13.4.1 Overview
13.4.2 Recent Developments
13.4.3 Revenue
13.5 Dr. Reddy’s Laboratories Ltd.
13.5.1 Overview
13.5.2 Recent Developments
13.5.3 Revenue
13.6 GlaxoSmithKline plc
13.6.1 Overview
13.6.2 Recent Developments
13.6.3 Revenue
13.7 Johnson & Johnson
13.7.1 Overview
13.7.2 Recent Developments
13.7.3 Revenue
13.8 Pfizer Inc.
13.8.1 Overview
13.8.2 Recent Developments
13.8.3 Revenue
13.9 Procter & Gamble Company
13.9.1 Overview
13.9.2 Recent Developments
13.9.3 Revenue
13.10 Sanofi S.A.
13.10.1 Overview
13.10.2 Recent Developments
13.10.3 Revenue
13.11 Sun Pharmaceutical Industries Ltd.
13.11.1 Overview
13.11.2 Recent Developments
13.11.3 Revenue
13.12 Takeda Pharmaceutical Company Limited
13.12.1 Overview
13.12.2 Recent Developments
13.12.3 Revenue

Companies Mentioned

  • Abbott Laboratories
  • AstraZeneca plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy’s Laboratories Ltd.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Pfizer Inc.
  • Procter & Gamble Company
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Table Information